Editas Medicine has raised over £77m over recent days to invest in biotechnology research. Its main area is gene editing, which looks into rewriting DNA to remove disorders. It is hoped such research could one day treat deadly diseases by modifying and ‘fixing’ faulty genes, as scientists can use it to correct the human genome and remove malfunctioning parts of the DNA.
Researchers at MIT have developed a new ultrasound patch that overcomes traditional barriers in ultrasound tech and brings medical imaging...
TFTEC Revolutionary Technology Restores Cold Sensation in Phantom Limbs: A Leap Forward for Amputees
For many amputees, losing a limb is just the beginning of a lifelong journey filled with challenges. One such challenge...
Nuclear fusion: how scientists can turn latest breakthrough into a new clean power source
Researchers in the US have finally fulfilled an objective that was set decades ago: the achievement of “ignition” – getting...
Nuclear fusion may still be decades away, but the latest breakthrough could speed up its development
Nuclear fusion holds huge promise as a source of clean, abundant energy that could power the world. Now, fusion researchers...
Breakthrough in nuclear fusion energy announced
We may be a step closer to realizing fusion power, which could provide an almost limitless source of energy. Researchers...
Pill-shaped biosensor keeps track of gut metabolites in real time
Looking to keep track of your gut health in real-time? A new pill-shaped biosensor may be able to help. The...
Meet the team who taught an AI to impersonate Shakespeare and Oscar Wilde
We taught an AI to impersonate Shakespeare and Oscar Wilde – here’s what it revealed about sentience Nay, nay, I say! This...
Nuclear fusion: how excited should we be?
There’s been tremendous excitement about recent results from the Joint European Torus (JET) facility in the UK, hinting that the...
